NYSE:GEN Genesis Healthcare (GEN) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free GEN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$22.15▼$22.4450-Day Range$0.18▼$0.6052-Week Range$0.40▼$1.37Volume3.05 million shsAverage Volume4.10 million shsMarket Capitalization$14.32 billionP/E Ratio24.89Dividend Yield2.23%Price Target$25.60 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSocial MediaStock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSocial Media Get Genesis Healthcare alerts: Email Address Genesis Healthcare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside14.3% Upside$25.60 Price TargetShort InterestN/ADividend StrengthModerateBased on Four FactorsSustainabilityN/ANews Sentiment0.00Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth5.52%From $1.63 to $1.72 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.82 out of 5 starsBusiness Services Sector215th out of 316 stocksPrepackaged Software Industry154th out of 200 stocks 2.4 Analyst's Opinion Consensus RatingGenesis Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $25.60, Genesis Healthcare has a forecasted upside of 14.3% from its current price of $22.40.Amount of Analyst CoverageGenesis Healthcare has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for GEN. Previous Next 2.5 Dividend Strength Dividend YieldGenesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenesis Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GEN. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 6 news articles for Genesis Healthcare this week, compared to 5 articles on an average week.Search InterestOnly 9 people have searched for GEN on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.MarketBeat Follows8 people have added Genesis Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Genesis Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Genesis Healthcare is held by insiders.Percentage Held by Institutions82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Genesis Healthcare is 24.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.21.Price to Earnings Ratio vs. SectorThe P/E ratio of Genesis Healthcare is 24.89, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 28.92. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Genesis Healthcare Stock (NYSE:GEN)Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now GEN Stock News HeadlinesMarch 28, 2024 | msn.comReGenesis Health Care expands presence in DuncanMarch 27, 2024 | msn.comFirst public health vending machine unveiled in Outagamie CountyMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 27, 2024 | msn.comGenesis 'Magma' GV60 and G80 performance vehicles get New York Auto Show revealMarch 25, 2024 | finance.yahoo.comShould We Be Delighted With Gen Digital Inc.'s (NASDAQ:GEN) ROE Of 58%?March 24, 2024 | msn.comM.E.A.N. Girls Empowerment to shine light on health disparities at Girls Health Matters SummitMarch 22, 2024 | finance.yahoo.comBringing Clean Water to Rural IndiaMarch 21, 2024 | yahoo.comTricare Beneficiaries Log 30,000 Prescription Refills in First Week of Electronic Health Record System Taking OrdersMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 20, 2024 | msn.comStaff-Related Issues Plague Car Brand Health ScoresMarch 20, 2024 | finance.yahoo.comGen Wins Recognition for Its Commitment to InclusionMarch 19, 2024 | yahoo.comQC endocrine practice to merge with GenesisMarch 18, 2024 | finance.yahoo.comCelebrating Women’s Month: From Empowerment to ActionMarch 16, 2024 | msn.comBest Sega Genesis GamesMarch 15, 2024 | msn.comColon Cancer | Genesis Medical MomentsMarch 15, 2024 | msn.comColon Cancer Screening | Genesis Medical MomentsMarch 14, 2024 | finanznachrichten.deWebcor Delivers World's 1st TRUE-Certified Construction Project at GENESIS MarinaMarch 14, 2024 | msn.comGenesis G70, G80, and G90 Recalled for Fire RiskMarch 14, 2024 | prnewswire.comTax Prep Service Scams Rank High on Taxpayers' List of Concerns This Filing SeasonMarch 13, 2024 | finance.yahoo.comGenesis, Gemini Must Face SEC Suit Over Crypto ‘Earn’ ProgramMarch 13, 2024 | markets.businessinsider.comEric Witte Named Chief Operating Officer of Genesis Orthopedics & Sports MedicineMarch 12, 2024 | investorplace.comThe 3 Most Undervalued Cybersecurity Stocks to Buy in March 2024March 6, 2024 | msn.comMarilynne Robinson makes the first book of the Old Testament new again in ‘Reading Genesis’March 6, 2024 | msn.comMuskingum Valley ESC introduces healthcare preceptorship program for high school studentsMarch 6, 2024 | finance.yahoo.comGenesis Research Group Announces Appointment of David W. Miller as CEOMarch 3, 2024 | msn.comTiger Woods to play in Seminole pro-member Monday weeks after Genesis withdrawalFebruary 28, 2024 | yahoo.comReproductive health was an election minefield for Republicans. It got worse with IVF.See More Headlines Receive GEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/01/2024Ex-Dividend for 3/13 Dividend2/15/2024Dividend Payable3/13/2024Today3/29/2024Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CUSIPN/A CIK1351051 Webwww.genesishcc.com Phone610-444-6350Fax302-636-5454Employees2,700Year FoundedN/APrice Target and Rating Average Stock Price Target$25.60 High Stock Price Target$28.00 Low Stock Price Target$23.00 Potential Upside/Downside+14.3%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio24.89 Forward P/E Ratio13.74 P/E GrowthN/ANet Income$836 million Net Margins17.83% Pretax Margin23.69% Return on Equity155.48% Return on Assets9.12% Debt Debt-to-Equity Ratio7.50 Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual Sales$2.80 billion Price / Sales5.12 Cash Flow$2.66 per share Price / Cash Flow8.42 Book Value($0.16) per share Price / Book-140.00Miscellaneous Outstanding Shares639,130,000Free Float618,038,000Market Cap$14.32 billion OptionableOptionable Beta0.84 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Robert H. Fish (Age 70)CEO & Director Comp: $411.5kMr. Thomas DiVittorio (Age 53)Exec. VP & CFO Comp: $565kMr. Paul David Bach (Age 62)COO & Exec. VP Comp: $630kMr. Stephen Scott Young (Age 49)Chief Accounting Officer & Treasurer Mr. Richard L. Castor (Age 66)Chief Information Officer & Sr. VP Mr. James W. Tabak (Age 62)Sr. VP of Admin. & Gov. Affairs Ms. Lori MayerVP of Investor Relations, Brand Management & Marketing CommunicationsMr. Michael Scott Sherman (Age 52)Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer Mr. Larry BaiderSr. VP of People Strategy & OperationsDr. JoAnne Susan Reifsnyder R.N. (Age 62)Ph.D., Ph.D., ACHPN, MSN, MBA, RN, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer More ExecutivesKey CompetitorsUiPathNYSE:PATHDocuSignNASDAQ:DOCUProcore TechnologiesNYSE:PCORElasticNYSE:ESTCConfluentNASDAQ:CFLTView All CompetitorsInsiders & InstitutionsNomura Holdings Inc.Bought 11,356 shares on 3/27/2024Ownership: 0.002%Quadrature Capital LtdBought 49,602 shares on 3/25/2024Ownership: 0.008%PNC Financial Services Group Inc.Bought 3,682 shares on 3/22/2024Ownership: 0.007%B. Riley Wealth Advisors Inc.Bought 14,775 shares on 3/15/2024Ownership: 0.002%Vanguard Group Inc.Sold 247,971 shares on 3/11/2024Ownership: 10.573%View All Insider TransactionsView All Institutional Transactions GEN Stock Analysis - Frequently Asked Questions Should I buy or sell Genesis Healthcare stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GEN shares. View GEN analyst ratings or view top-rated stocks. What is Genesis Healthcare's stock price target for 2024? 5 Wall Street analysts have issued 1-year price objectives for Genesis Healthcare's stock. Their GEN share price targets range from $23.00 to $28.00. On average, they anticipate the company's share price to reach $25.60 in the next year. This suggests a possible upside of 14.3% from the stock's current price. View analysts price targets for GEN or view top-rated stocks among Wall Street analysts. How were Genesis Healthcare's earnings last quarter? Genesis Healthcare, Inc. (NYSE:GEN) released its quarterly earnings data on Thursday, February, 1st. The company reported $0.45 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.45. The business earned $953 million during the quarter, compared to analysts' expectations of $955.80 million. Genesis Healthcare had a net margin of 17.83% and a trailing twelve-month return on equity of 155.48%. How often does Genesis Healthcare pay dividends? What is the dividend yield for Genesis Healthcare? Genesis Healthcare declared a quarterly dividend on Thursday, February 1st. Stockholders of record on Monday, February 19th will be given a dividend of $0.125 per share on Wednesday, March 13th. This represents a $0.50 annualized dividend and a yield of 2.23%. The ex-dividend date is Thursday, February 15th. Read our dividend analysis for GEN. Is Genesis Healthcare a good dividend stock? Genesis Healthcare (NYSE:GEN) pays an annual dividend of $0.50 per share and currently has a dividend yield of 3.05%. The dividend payout ratio is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GEN will have a dividend payout ratio of 29.07% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for GEN. What ETFs hold Genesis Healthcare's stock? ETFs with the largest weight of Genesis Healthcare (NYSE:GEN) stock in their portfolio include Amplify Cybersecurity ETF (HACK), Global X Cybersecurity ETF (BUG), First Trust Nasdaq Cybersecurity ETF (CIBR), iShares Virtual Work and Life Multisector ETF (IWFH), ASYMshares ASYMmetric S&P 500 ETF (ASPY), First Trust S&P 500 Diversified Dividend Aristocrats ETF (RNDV), Invesco S&P 500 Equal Weight Technology ETF (RSPT) and Invesco S&P 500 Equal Weight Technology ETF (RYT). What guidance has Genesis Healthcare issued on next quarter's earnings? Genesis Healthcare issued an update on its fourth quarter 2024 earnings guidance on Thursday, February, 1st. The company provided earnings per share guidance of 0.520-0.540 for the period, compared to the consensus EPS estimate of 0.530. The company issued revenue guidance of $960.0 million-$970.0 million, compared to the consensus revenue estimate of $974.4 million. What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN), Government Properties Income Trust (GOV), Advanced Micro Devices (AMD), Bausch Health Companies (BHC) and Who are Genesis Healthcare's major shareholders? Genesis Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.57%), Vanguard Group Inc. (10.57%), Boston Partners (2.76%), Beutel Goodman & Co Ltd. (2.05%), Legal & General Group Plc (1.80%) and Franklin Resources Inc. (1.76%). Insiders that own company stock include Natalie Marie Derse and Ondrej Vlcek. View institutional ownership trends. This page (NYSE:GEN) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.